Drug-like molecule can counteract the effects of mutated epigenetic regulators that drive cancers

A decade ago, genome sequencing revealed a big surprise: about 50 percent of human cancers are linked to mutations in what are known as epigenetic regulators, which control the activity of genes.

Related Keywords

Oliver Bell ,Stephenv Frye ,Junghyunl Suh ,Emily Henderson ,University Of North Carolina At Chapel Hill ,Norris Comprehensive Cancer Center ,Keck School Of Medicine ,Cell Chemical Biology ,North Carolina ,Chapel Hill ,Keck School ,Comprehensive Cancer ,Fred Eshelman Distinguished Professor ,Integrative Chemical Biology ,Drug Discovery ,Cancer ,Olecule ,Fell ,Drugs ,Gene ,Genes ,Enome ,Lymphoma ,Medicine ,Protein ,Research ,Stem Cells ,